New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
08:36 EDTCOSICosi receives Nasdaq notice of minimum stockholder equity non-compliance
Cosė announced that it had received notice from the Nasdaq Stock Market indicating that as of the date of the filing of its Form 10-Q for the period ended March 31, the company has fallen below the $2.5M minimum level of stockholders equity required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). The notification letter states that the company will be afforded 45 calendar days, or until June 14, to submit a plan to regain compliance. If the plan is accepted, the company may be granted an extension of up to 180 calendar days from the date of notification, or until November 12 to evidence compliance. The notification letter has no effect at this time on the listing of the company's common stock on The Nasdaq Capital Market. Cosė's common stock will continue to trade on The Nasdaq Capital Market under the symbol "COSI".
News For COSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
09:00 EDTCOSICosi management to meet with FBN Securities
Subscribe for More Information
May 14, 2015
09:22 EDTCOSIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Perry Ellis (PERY), up 11.5%... Ctrip.com (CTRP), up 13.4%. ALSO HIGHER: AcelRx (ACRX), up 10.3% after being awarded contract worth up to $17M from Defense Dept to advance ARX-04... Oncothyreon (ONTY), up 16.9% after ASCO presentation data released... CYREN (CYRN), up 14.6% after announcing agreement with Dell.... Discovery Laboratories (DSCO), up 5.2% after Aerosurf shows positive Phase 2a data... Kate Spade (KATE), up 3.9% after being initiated with an Outperform at Wedbush. DOWN AFTER EARNINGS: Digital Ally (DGLY), down 16.4%... Kohl's (KSS), down 10.2%... VOXX (VOXX), down 8.1%... Cosi (COSI), down 7.3%. ALSO LOWER: Biotechnology (PBYI), down 15.1%% after Neratinib data published in ASCO abstract... Gevo (GEVO), down 10.7% after 4.3M share Spot Secondary priced at $4.00.
06:38 EDTCOSICosi reports Q1 EPS (12c), one estimate (1c)
Subscribe for More Information
May 13, 2015
16:35 EDTCOSICosi files to sell 13.94M shares of common stock for holders

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use